Introduction
============

Prion diseases or transmissible spongiform encephalopathies (TSEs) are fatal neurological disorders that include Creutzfeldt-Jakob disease (CJD) and kuru in humans, scrapie in sheep and goats, bovine spongiform encephalopathy (BSE) in cattle, and chronic wasting disease (CWD) in cervids. For the last 30 years, we and other Japanese groups have reported Japanese scrapie and BSE cases.^[@r01]--[@r14])^ Hitherto, 36 cases of BSE^[@r10],[@r13])^ have been reported in Japan (Fig. [1](#fig01){ref-type="fig"}). Global elucidation of the etiology of kuru has lead to the discovery of pre-senile dementias, CJD and its variant --- with basically similar cellular lesions --- which are also transmissible and may be caused by a very similar and unconventional "virus" or prion.^[@r15],[@r16])^ All the transmissible cerebral amyloidoses (TCA) are formed from the TCA amyloid precursor protein (PrP) specified on the short arm of chromosome 2 in humans and chromosome 20 in mice.

There are other slow infections of the central nervous systems in humans that are caused by conventional viruses, including measles virus, papovaviruses (JC virus and SV40-progressive multifocal leukoencephalopathies or PML), rubella virus, cytomegalovirus, herpes simplex virus, adenovirus types 7 and 32, Russian spring-summer encephalitis (RSSE) viruses, and the human retroviruses (human T-cell lymphotropic viruses-1: HTLV1, and human immunodeficiency viruses: HIV) (Table [1](#tbl01){ref-type="table"}). Recently, Notkins's group, our and other groups have demonstrated that human enteroviruses and reoviruses can be regarded as typical slow infections causing type-1 diabetes mellitus.^[@r17]--[@r25])^ However, unlike these conventional viruses, the "unconventional viruses" of the subacute spongiform encephalopathies are truly slow in their replication, with long doubling times. Moreover, these alone appear to be viruses that have made it necessary to alter our conceptions of the possible range of virus structure. The process of infection appears to be a seeding by a "virus", which is a nucleating agent inducing and the automatically accelerating the conformational transition in the amyloid subunit protein. In that process the host-specified precursor protein (cellular isoform of prion protein: PrP^C^) is converted to an insoluble cross-β-plated configuration (scrapie isoform of prion protein: PrP^Sc^)^[@r26])^ (Table [2](#tbl02){ref-type="table"}). Oligomers of microfilament of this subunit protein nucleate its own polymerization, crystallization, and precipitation as insoluble arrays of amyloid fibrils. Thus, proteolytic cleavage and conformational change of the precursor and oligomeric assembly of this structurally altered polypeptide produces a fibril amyloid enhancing factor^[@r27])^ with apparent infectious properties. In this report, the dual role of PrP^C^ is described in diseased and normal function in the compromised host. Additionally, the etiological role of PrP^C^ in the induction of Alzheimer's disease (AD) is discussed.

1. PrP^C^ is indispensable for neurological functions
=====================================================

1). Neuritogenesis by PrP^C^.
-----------------------------

The mammalian PrP^C^ is a highly conserved glycoprotein localized in membrane lipid rafts and anchored to the cell surface by glycosylphpsphatidylinositol (GPI).^[@r28],[@r29])^ PrP^C^ is located in many cell types, and is particularly abundant in neurons.^[@r30])^ Under certain conditions PrP^C^ may undergo conversion into a conformationally altered isoform (PrP^Sc^) which is widely believed to be the pathogenic agent in prion disease or TSE.^[@r31])^ Although much has been studied about the effects of PrP^Sc^ in prion diseases, the normal function of PrP^C^ is poorly understood as yet. Lehmann and our group have shown that PrP^C^ has α- and β-cleavage site during normal processing and host translational modifications.^[@r32])^

Recent experimental evidence showing that PrP^C^ interacting with β1 integrin controls focal adhesion and turnover of the actin microfilaments in neurons substantiates a role for PrP^C^ in neuritogenesis. Several reports show that PrP^C^ participates in trans-membrane signaling processes associated with hematopoietic stem cell replication and neuronal differentiation.^[@r33]--[@r35])^ Integrins are well known in autophagy. Remarkably, during neuronal differentiation, the downregulation of Rho kinase activity is necessary for neurite sprouting.^[@r33])^ Abundant expression of PrP^C^ has been detected during mouse embryogenesis in association with the developing mouse nervous system.^[@r36])^ In the developing mouse brain, undifferentiated neural progenitor cells in the mitotically active ventricular zone do not express PrP^C^. In contrast, post-mitotic neurons express high levels of PrP^C^ after their last mitosis in the neuroepithelium as they migrate towards marginal layers and differentiate.^[@r36],[@r37])^ Thus, PrP^C^ may be expressed exclusively in differentiated neurons.

Studies *in vitro* have shown that expression of PrP^C^ is positively correlated with differentiation of multipotent neuronal precursors into mature neurons.^[@r37])^ In addition, treatment of embryonic hippocampal neurons with recombinant PrP^C^ enhance neurite outgrowth and survival.^[@r38])^ The distribution of PrP^C^ in the developing nervous systems of cattle,^[@r39])^ mice,^[@r36])^ and humans^[@r40])^ suggest that PrP^C^ plays a functional role in neural development. While PrP^C^-knockout (*Prnp*^−/−^) displays no overt in neural phenotype,^[@r41])^ numerous subtle phenotypes have been reported,^[@r37])^ including reduction in the number of neural precursor cells in developing mouse embryo.^[@r35])^ Other studies have shown that PrP^C^ induced neuritogenesis in embryonic hippocampal neurons cultured *in vitro*.^[@r38],[@r42])^ PrP^C^ interacts with stress-inducible protein 1 (STI1),^[@r43])^ which is a heat-shock protein.^[@r44])^ The interaction of PrP^C^ with STI1 not only activates cyclic adenosine monophosphate (cAMP)-dependent protein kinase A (PKA) to transduce a survival signal but also induces phosphorylation/activation of the mitogen-activated protein kinase to promote neuritogenesis.^[@r42])^ Elucidation of the signaling pathways through which PrP^C^ influences neurogenesis, along with an understanding of the pathways involved in other key cellular processes,^[@r42])^ may provide insight into how PrP^C^ misfolding leads to devastating neurodegenerative diseases.

2). Neuroprotection by PrP^C^.
------------------------------

In this chapter we describe how our group has spent much effort to understand the normal function of PrP^C^ using *Prnp*^−/−^ mice. Interestingly we observed that PrP^C^ worked in an *in vitro* system favorably provide neuroprotection for mice under the oxidative stress or virus infection by suppressing the apoptosis. In this chapter and Chapter 4, we show the same neuroprotective role of PrP^C^ in an *in vivo* mouse system. The most commonly observed function on PrP^C^ is copper-binding. Previous and our studies by our laboratories and others have demonstrated that the octapeptide-repeat region of PrP^C^ binds with Cu^2+^ within the physiological concentration range.^[@r45]--[@r47])^ Furthermore, PrP^C^ displays a functional role in normal brain metabolism of copper.^[@r48])^ Besides binding with Cu^2+^ at the synapse, PrP^C^ serves as Cu^2+^ buffer as well.^[@r49])^ Overexpression of PrP^C^ increases Cu^2+^ uptake into cells,^[@r50])^ while PrP^C^-knockout (*Prnp*^−/−^) mice show a lower synaptosomal Cu^2+^ concentration than normal mice.^[@r49])^ However, Cu^2+^ rapidly and reversibly stimulates the internalization of PrP^C^ during PrP^C^ endocytosis.^[@r51],[@r52])^ Through binding with Cu^2+^, PrP^C^ displays superoxide dismutase (SOD) activity *in vitro*.^[@r50],[@r53]--[@r57])^ Intriguingly, treatment with copper chelator cuprizone induces TSE-like spongiform degeneration.^[@r58])^ Therefore, Cu^2+^ metabolism appears to play an important role in not only PrP function but also the pathogenesis of prion diseases.

PrP^C^ may act as an antiapoptotic agent by blocking some of the internal or environmental factors that initiate apoptosis.^[@r59],[@r60])^ Mature PrP^C^ trends to localize in lipid rafts of cells.^[@r30])^ As lipid rafts are membrane structures specialized in signaling, a potential role of PrP^C^ in signal transduction may be anticipated. Aβ on the raft is the most important interacting protein among them (see the next chapter: section 3). Such a signaling platform or signalosome is based on PrP^C^. PrP^C^ localizes to cholesterol- and sphingolipid-rich, detergent-resistant lipid rafts due to the saturated acryl chains in its GPI anchor and to an N-terminal targeting signal interacting with heparin sulfate proteoglycan, glypican-1. PrP^C^ has been proposed as a key scaffolding protein for dynamic assembly of cell surface signaling modules, and PrP^C^, along with the microdomain-forming flotillin, or caveolin proteins, may lead to the local assembly of membrane protein complexes at sites involved in cellular communication, such as cell-cell contacts, focal adhesions, the T-cell cap, and synapses.

In addition, a phosphorylating function of PrP^C^, mediated by caveolin-1 to indirectly increase Fyn (a member of the Src family of tyrosine kinase) phosphorylation, governs the downstream production of NADPH-oxidase-dependent reactive oxygen species and activation of the extracellular regulated kinase 1/2 has been demonstrated.^[@r30],[@r61])^ PrP^C^ interacts with normal phosphoprotein synapsin Ib and cytoplasmic adaptor protein Grb2 without being deciphered with prion interactor Pint1.^[@r62])^ Bovine PrP strongly interacts with the catalytic α/α′ subunit of protein kinase CK2 to increase the phosphotransferase activity of CK2, thus leading to the phosphorylation of calmodulin.^[@r63])^

Upon engagements with PrP^C^ binding peptides and certain antibodies, PrP^C^ transduces neuroprotective signals that affect the sensitivity to induce cell death.^[@r64])^ Linden *et al.* have suggested that the engagement of PrP^C^ transduces neuroprotective signals through a cAMP/PKA-dependent pathway. According to their theory, PrP^C^ may function as a trophic receptor, where the activation of which leads to a neuroprotective state.^[@r64])^ In addition, PrP^C^ binds with extracellular matrix laminin to promote genesis and maintenance of neurites. We have shown that PI3K is activated by PrP^C^ through the intercellular transportation of copper molecules.^[@r65])^ In fact, a study has discovered PrP^C^ to induce self-renewal of long-term populating hematopoietic stem cells.^[@r34])^ Furthermore, another study has revealed that PrP^C^ is expressed on the multipotent neural precursors and mature neurons without being detected in glia, suggesting that PrP^C^ plays an important role in neural differentiation.^[@r39])^ Therefore, the interaction between PrP^C^ and various signal transduction molecules speaks well for important functions (such as differentiation and cell survival) in the living system (Fig. [2](#fig02){ref-type="fig"}).

A stress-protective activity has also been assigned to PrP^C^ based on results with primary neuronal cultures. Neuronal cells derived from *Prnp*^−/−^ mice are more sensitive to oxidative stress and serum deprivation than wild-type cells. Moreover, after ischemic brain injury, *Prnp*^−/−^ mice reveal enlarged infarct volumes.^[@r66])^ In our studies *Prnp*^−/−^ cell line (HpL3-4), immortalized from hippocampal neuronal precursor cells in Rikn *Prnp*^−/−^ mice (Fig. [3](#fig03){ref-type="fig"}), is sensitive to serum deprivation-induced apoptosis, although it is activated and/or survives with PrP^C^ expression.^[@r53])^ The same effect was observed in another *Prnp*-deficient cell line (NpL2), immortalized from hippocampal neuronal cells in Zrch I *Prnp*^−/−^ mice.^[@r57])^ Overexpression of B-cell lymphoma 2 protein (Bcl-2) in this cell line reveals a functional relation of PrP^C^ with Bcl-2 in the anti-apoptotic pathway.^[@r53])^ Martin *et al.* have shown that prevention of cell death in cultured retinal explants from neonatal rats and mice induced by anisomycin (a protein synthesis inhibitor) unfurls the effect associated with PrP^C^-STI1 interactions.^[@r43])^ Li and our group show that the production of another type of heat-shock protein (Hsp 70) is enhanced when PrP levels elevate during hyperglycemia.^[@r67])^

We have demonstrated that the inhibition of apoptosis through STI1 is mediated by PrP^C^-dependent SOD activation.^[@r68])^ This neuroprotective role of PrP^C^ has been linked to cell signaling events. The interaction of PrP^C^ with the STI1 generates neuroprotective signals that rescue cells from apoptosis (Fig. [4](#fig04){ref-type="fig"}). The functional role of STI1 and PrP^C^ have been confirmed in both murine and bovine systems.^[@r69])^ The late onset of severe ataxia and loss of cerebellar Purkinje cells in several *Prnp*^−/−^ mouse lines^[@r70]--[@r72])^ from several laboratories suggest the lack of cerebellar protection by PrP^C^ in these mice. Interestingly, deposition of PrP^Sc^ has been located in the deep cerebellar nuclei (DCN) of scrapie-infected sheep.^[@r73])^ Future studies with a microarray analysis^[@r74])^ by our group applied in eye-blink-conditioning of mice may provide insight into understanding the normal function of PrP^C^ in the DCN of the cerebellum.

A loss of PrP^C^ function could be implicated in the pathogenesis of prion diseases and PrP^C^-dependent pathways might be involved in neurotoxic signaling. For example, *in vivo* crosslinking of PrP^C^ by antibodies triggered neuronal apoptosis^[@r75])^ and PrP^C^-dependent receptors were postulated to explain the neurotoxic effect of a PrP mutant lacking the hydrophobic domain (see next sections 2 and 3).^[@r76])^ Still available data indicated that PrP^C^ is a critical element of the network that controls the sensitivity to programmed cell death in both the nervous system and several other cell types. The outcome of the engagement of PrP^C^ on either cell death or survival is likely dictated by its available ligands. These ligands in fact determine the array of intervening signaling pathways.

Taken together, PrP^C^ is functionally involved in copper metabolism, signal transduction, neuroprotection, and cell maturation. Despite these putative roles, mice null for PrP^C^ display no consistent phenotype apart from complete resistance to TSE infection.^[@r41],[@r77])^ Further searches for PrP^C^-interaction molecules using *Prnp*^−/−^ mice and various types of *Prnp*^−/−^ cell lines under various conditions may elucidate the PrP^C^ functions.

3). Enhanced synaptic plasticity by PrP^C^.
-------------------------------------------

In Rikn *Prnp*^−/−^ mice, Kim *et al.* in our group have observed pathological alterations and some physiological dysfunctions in the olfactory bulb (OB).^[@r78])^ Recently, Le Pichon *et al.* have proposed that electrophysiological alterations at the dendrodendritic synapse in the OB could underlie the behavior phenotypes.^[@r79])^ In detail, the cookie finding phenotype was manifested in three *Prnp*^−/−^ lines (Zrch I *Prnp*^−/−^ mice,^[@r41])^ Ngsk *Prnp*^−/−^ mice,^[@r72])^ Npu *Prnp*^−/−^ mice,^[@r80])^) on alternate genetic backgrounds, indicating strong evidence of its dependence on PrP^C^ rather than other genetic factors. *Prnp*^−/−^ mice also displayed altered behavior in the habituation-dishabituation task, suggesting the phenotype is most likely to be olfactory-specific.^[@r78],[@r79])^ *Prnp*^−/−^ mice exhibited wide spread alterations of oscillatory activity in the OB as well as altered paired-pulse plasticity at the dendrodendritic synapse. Importantly, both the behavioral and electrophysiological phenotypes could be rescued by neuronal PrP^C^ expression.^[@r79])^ These data suggest a critical role for PrP^C^ in the normal processing of sensory information by the olfactory system.

Kim *et al.* and Le Pichon *et al.* employed a so-called "cookie finding task", a test of broad olfactory acuity, to analyze a battery of mice including PrP knockout from multiple genetic backgrounds and transgenic mice in which *Prnp* expression was driven by cell type-specific promoters.^[@r78],[@r79])^ *Prnp*^−/−^ mice exhibited impaired behavior that was rescued in transgenic mice expressing PrP^C^ specifically in neurons but not in mice expressing only extra-neuronal PrP^C^. *Prnp*^−/−^ mice displayed altered behavior in an additional olfactory test (habituation-dishabituation) which was also rescued by transgenic neuronal PrP expression suggesting that the phenotype was olfactory-specific. Additionally, the odor-evoked electrophysiological properties of the OB of *Prnp*^−/−^ mice have been studied.^[@r79])^ In these mice, alterations in the patterns of oscillatory activity in the OB were detected. The plasticity of dendrodendritic synaptic transmission was altered between the granule cells and mitral cells.

Disruption was observed in local field potential (LFP) oscillation and in the plasticity of the dendrodendritic synapse, either, or both, of which could contribute to the behavioral phenotype in *Prnp*^−/−^ mice. Oscillatory LFPs may act to organize information flow within the olfactory system^[@r81],[@r82])^ by constraining the timing of mitral cell action potentials. In addition, gamma oscillations are specifically implicated in behavioral performance in olfactory tasks.^[@r83],[@r84])^ Therefore, alterations in oscillatory timing during odor exposure may perturb OB output to higher centers by disrupting how information is packaged within a breathing cycle.

Altering the dendrodendritic synapse may have multiple functional consequences. This synapse may mediate lateral inhibition between ensembles of mitral cells, and be critical for olfactory discrimination.^[@r85],[@r86])^ Additionally, because granule cells receive convergent information onto their proximal dendritic arbor from multiple higher brain areas,^[@r87])^ disruption of the dendrodendritic synapse may alter the transmission of centrifugal modulation of OB mitral cells.

High-frequency oscillations in the OB are shown to result from the rapid and reciprocal interactions between granule and mitral cells across the dendrodendritic synapse *in vitro*.^[@r88])^ Therefore, Le Pichon's observation could imply that increased facilitation of mitral cell inhibitory postsynaptic potential (IPSP) following repetitive spiking decreases the dynamic range and increases the duration of gamma oscillations across the boundaries of breath. Although both oscillatory and synaptic effects could be reversed by neuronal PrP^C^ expression, they cannot claim a causal link between these findings. Mitral cells receive facilitated inhibition in *Prnp*^−/−^ mice. Future work should determine the precise synaptic localization of the PrP^C^ protein as well as its biochemical interactions with synaptic machinery.

At least two definite molecular interactions of PrP^C^ with hippocampal cell surface proteins, STI1 and laminin, can mediate the effect of PrP^C^ on memory consolidation.^[@r89])^ Moreover, it is likely that PrP^C^ modulates memory retention through both these interactions. Further support of the hypothesis that PrP^C^ plays important roles in memory and cognition is found in humans.^[@r89])^ The presence of Val at codon 129 of *PRNP* (human prion protein gene) in at least one allele is associated with worsened cognitive performance in elderly subjects, with early cognitive decline.^[@r89])^ Conversely, healthy young adults expressing Met at codon 129 in at least one allele exhibit better long-term memory than those with Val in this codon, although short-term memory was unaffected. Thus, polymorphism at codon 129, a site that is highly important for protein structure, seems to be strongly related to cognitive performance.^[@r89])^

Another report shows the potential impact of the temporary disruption of the cerebellar circuit during the time window critical for sensorimotor development in Zrch I *Prnp*^−/−^ mice.^[@r90])^ In that investigation, the authors considered the effect of PrP gene knock-out on cerebellar neural circuits, which show intense PrP expression during development and selective affinity for PrP. Zrch I *Prnp*^−/−^ mice showed low performance in the acclerating rotarod and runaway test and the functioning of 40% of granule cells was abnormal. This phenomenon may have a reflection in some of the late motor, cognitive, and emotional abnormalities in Zrch I *Prnp*^−/−^ mice.^[@r90])^ Their results suggest that PrP plays an important role in granule cell development to eventually regulate cerebellar network and motor control.

4). Myelination in peripheral nerves by PrP^C^.
-----------------------------------------------

A late-onset peripheral neuropathy has been identified in PrP^C^-deficient Ngsk *Prnp*^−/−^ and Zrch I *Prnp*^−/−^ mice^[@r41],[@r72],[@r91])^ (Fig. [4](#fig04){ref-type="fig"}). This indicates that PrP^C^ might have a role in peripheral neuropathies. At 60 weeks of age, all investigated Zrch I *Prnp*^−/−^ mice (n = 52) showed chronic demyelinating polyneuropathy (CDP).^[@r92])^ CDP was 100% penetrating and conspicuous in all investigated peripheral nerves (sciatic and trigeminal nerves, dorsal and ventral spinal roots) (Fig. [4](#fig04){ref-type="fig"}). Besides, CDP was associated with another 2 independently targeted *Prnp* knockout mouse lines, GFP *Prnp*^−/−^ mice^[@r93])^ and Npu *Prnp*^−/−^ mice.^[@r80])^

Zrch I *Prnp*^−/−^ and Npu *Prnp*^−/−^ mice suffered from CDP despite normal expression of Doppel (Dpl),^[@r70])^ indicating that Dpl regulation did not cause polyneuropathy. CDP was present in mice lacking both *Prnp* and *Prnd* (the gene for Dpl),^[@r94])^ but absent from mice selectively lacking *Prnd*.^[@r95])^ Therefore, Dpl is not required for the maintenance of peripheral nerves. PrP^C^ might interact with myelin component directly or through other axonal proteins. Certain reported PrP^C^ interacting proteins have roles in homeostasis,^[@r96])^ and represent possible candidates for mediation of its myelinotrophic effects. The octapeptide repeat region was not required for myelin maintenance, whereas mice PrP lacking central domain (aa 94-134) developed CDP.^[@r97])^ It is worthy to note that the hydrophobic core, but not the charge cluster (CC~2~), of this central PrP^C^ domain was essential for peripheral myelin maintenance.

Our and many other recent reports have shown that PrP^C^ undergoes regulated proteolysis in late secretory compartments.^[@r32],[@r98]--[@r100])^ Bremer *et al.*^[@r92])^ have observed an association between the presence of CDP and lack of C1 fragment in the sciatic nerves. All PrP^C^ mutants in which CDP was rescued produced abundant C1.^[@r92])^ CDP was prevented by PrP^C^ variants that undergo proteolytic amino-proximal cleavage,^[@r32])^ but not by variants that undergo nonpermissive cleavage, including secreted PrP^C^ lacking its glycolipid membrane anchor. Cleavage of PrP^C^ appeared therefore to be linked to its myelinotrophic function. This conjuncture might also explain the requirement for membrane anchoring of PrP^C^ uncovered in GPI-deficient PrP transgenic (^tg^GPI-PrP) mice,^[@r101])^ as anchorless PrP^C^ did not undergo regulated proteolysis. These results indicate that neuronal expression and regulated proteolysis of PrP^C^ are essential for myelin maintenance.^[@r92])^

Nervous myelin degeneration in optic nerves, corpus callosum or spinal cords was not detected in 60-week-old Zrch I *Prnp*^−/−^ mice.^[@r92])^ Nevertheless subliminal myelin pathologies might extend to central myelin in Zrch I *Prnp*^−/−^ mice,^[@r102])^ and transgenic mice expressing toxic PrP^C^ show both peripheral and central myelinopathies.^[@r97],[@r103])^ PrP^C^ deficiency has been reported to affect synaptic function,^[@r104],[@r105])^ however, the amplitudes of foot muscle compound action potentials following distal stimulation are not significantly altered in 53-week-old Zrch I *Prnp*^−/−^ mice; arguing against an important synaptic defect in the neuromuscular synaptic junction.

It has been suggested that PrP^C^ has various roles in immunity,^[@r106])^ and lymphocytes are important in mouse models of hereditary demyelinating neuropathies. As the CDP in our mutant mice was not modulated by *Rag1* removal, lymphocytes were not involved in its pathogenesis. The combined results of restricting expression of PrP^C^ of neurons and of selectively depleting PrP^C^ from neurons indicate that the expression of PrP^C^ by the neuron is essential for the long-term integrity of peripheral myelin sheaths.^[@r92])^ Not only was the trophic function of PrP^C^ exerted *in trans*, but also correlated with the proteolytic processing of in diverse transgenic mouse models. These findings identify PrP^C^ as a critical messenger of transcellular axomyelinic communication, and indicate that regulated proteolysis of axonal PrP^C^ might expose domains that interact with Schwann cell receptors. Recently, Aguzzi's group has reported that PrP^C^ promotes myelin homeostasis through flexible tail (23-50)-mediated Gpr126 agonism,^[@r107])^ and Gpr126 is crucial for peripheral nerve development. *Gpr126*^−/−^ mice exhibit drastic hypomyelination.^[@r107])^ Clarifying the molecular basis of these phenomena might lead to better understanding of peripheral neuropathies, particularly those with late-onset, and might help to uncover new therapeutic targets.

2. PrP^C^ mediates toxic signaling by PrP^Sc^
=============================================

Mice with prion disease show PrP^Sc^ accumulation and develop extensive neurodegeneration, in contrast to mouse models of AD or Parkinson's disease, where neuronal loss is rare. Therefore, prion-infected mice allow access to mechanisms linking protein misfolding to neuronal death. Studies of both neuronal and nonneuronal cells substantiate the coupling of PrP^C^ to signaling effectors involved in cell survival, redox equilibrium and homeostasis (*e.g.*, ERK1/2, NADPH oxidase, cyclic AMP-responsive element binding protein (CREB) transcription factor and metalloproteinases) (Fig. [2](#fig02){ref-type="fig"}). According to these studies, PrP^C^ functions as a dynamic cell surface platform for assembly of signaling molecules. However, the sequence of cellular and molecular events that leads to neuronal cell demise in TSEs remains obscure. At present, we envision that neuronal cell death results from several parallel, interacting or sequential pathways involving protein processing and proteasome dysfunction, oxidase stress, apoptosis, and autophagy.

The fact that PrP^Sc^ levels alone cannot serve as a marker for tissue infectivity suggests that it may be useful to adapt current protocols of prion detection in tissues, since they are so far largely based on the detection of bona fide PrP^Sc^.^[@r108])^ Mallucci's group has previously shown rescue of neuronal loss and reversal of early cognitive and morphological changes in prion-infected mice by depleting PrP^C^ in neurons, preventing prion replication and abrogating neurotoxicity.^[@r109])^ Recently, the same group has shown that PrP^Sc^ replication causes sustained unfolded protein response (UPR) induction with persistent, deleterious expression of eLF2α-P in prion disease.^[@r110])^ The resulting chronic blockade of protein synthesis leads to synaptic failure, spongiosis, and neuronal loss. Promoting eLF2α-P dephosphorylation rescues vital translation rates and is thereby neuroprotective, whereas preventing this further reduces translation and enhances neurotoxicity. The data support the development of generic proteostatic approaches to therapy in prion diseases.^[@r111],[@r112])^ The unfolded PrP^C^ response works as a protective cellular mechanism triggered by rising levels of misfolded PrP^Sc^ protein.^[@r110])^

In another study, expression of PrP^C^ in neuronal cells is required to mediate neurotoxic effects of PrP^Sc^,^[@r101])^ which might elicit a deadly signal through a PrP^C^-dependent signaling pathway. Spontaneous neurodegeneration in transgenic mice expressing a PrP^C^ mutant without the N-terminal ER-targeting sequence indicated the toxic potential of PrP^C^ when located in the cytosolic compartment (cytoPrP).^[@r113])^ Toxicity of cytoPrP seems to be dependent on its association with cellular membranes^[@r114])^ and its binding to Bcl-2, an antiapoptotic protein present at the cytosolic side of ER and mitochondrial membranes.^[@r115])^ Might the toxic potential of misfolded PrP^C^ in the cytosol be relevant to the pathogenesis of prion diseases? The most recent finding has revealed an impairment of the ubiquitin-proteasome system (UPS) in prion-infected mice. In conjunction with *in vitro* and cell culture approaches, it has been proposed that prion neurotoxicity is linked to PrP^Sc^ oligomers, which translocate to the cytosol and inhibit the UPS.^[@r116])^ Another study shows that a reduction in autophagy combined with endosomal/lysosomal dysfunction has indeed been proposed for the development of prion diseases.^[@r117])^

3. Role of PrP^C^ in AD
=======================

PrP^C^ is anchored to the cell surface by GPI. Since the 1980s, PrP-related studies have mainly focused on the mechanisms by which PrP^C^ is converted into PrP^Sc^ that is responsible for transmissible spongiform encephalopathies (TSE) and causes fatal neurodegeneration and aggregation. Concomitantly, the physiology of PrP^C^ has also been studied, including the role in the cellular trafficking of copper ions, hippocampal morphology, cognition, oxidative stress and apoptosis^[@r118])^ (Fig. [5](#fig05){ref-type="fig"}). Depending on cell context or physiological conditions, PrP^C^ is beneficial or harmful to the cell. Many studies have indicated that PrP^C^ can rescue neurons from various stressful situations.^[@r53],[@r119])^ Evidence from *Prnp*-knockout mice studies has provided information regarding subtle phenotypes (*e.g.*, mild neuropathological, cognitive and behavioral deficits),^[@r120])^ and enhanced brain injury after ischemia.^[@r66],[@r121])^ In addition, the N-terminal region of PrP^C^ displays a neuroprotective function.^[@r122])^ Conversely, PrP^C^ also tends to function as a neurotoxic protein.^[@r123])^

PrP^C^ expression is indispensable for prion-induced neurotoxicity to develop^[@r124])^ implying PrP^C^ could be a receptor for prions to trigger detrimental signaling. Strittmatter has reported that PrP^C^ transduces the synaptic cytotoxicity of amyloid-β(Aβ) oligomers *in vitro*^[@r125])^ and in Aβ-transgenic mice.^[@r126])^ Moreover, different anti-PrP antibodies or their antigen-binding fragments that disrupt the PrP-Aβ interaction are able to block the Aβ-mediated disruption of synaptic plasticity. These findings are important because they suggest the involvement of PrP^C^ in AD pathogenesis. However, others have found that the absence of PrP^C^ does not prevent deficits in hippocampal-dependent behavioral tests upon intracerebral Aβ injection.^[@r127])^ It has been suggested that variations in copper availability may contribute to these discrepancies.^[@r128])^

PrP^C^ seems to regulate the β-secretase cleavage of amyloid precursor protein, thereby regulating the production of Aβ.^[@r129])^ In addition, α-secretase regulates the cleavage of PrP^C^, regulating an N-terminal fragment with neuroprotective activity.^[@r122],[@r130])^ PrP^C^ also binds to transmembrane proteins such as the 67-kDa laminin receptor^[@r131])^ neural cell adhesion molecules,^[@r131],[@r132])^ G protein-coupled serotonergic receptors,^[@r64])^ and low density lipoprotein receptor-related protein 1 (LPR1),^[@r133],[@r134])^ which are able to promote intracellular signaling-mediated neuronal adhesion and differentiation as well as PrP^C^ internalization. Remarkably, PrP^C^ functions as a receptor or co-receptor for extracellular matrix proteins such as laminin^[@r65])^ and vitronectin,^[@r135])^ as well as STI1^[@r136])^ which has been repeatedly found by our group. These data suggest that GPI-anchored PrP^C^ is a potential scaffold receptor in a multiprotein, cell surface, and signaling complex that may serve as the basis for the multiple neuronal functions ascribed to PrP^C^.^[@r89],[@r137])^

PrP^C^ has been identified to bind Aβ oligomers (AβO), but not monomers or fibrils, with high affinity and to selectively interact with high molecular mass assembles of AβO in AD but not control brains.^[@r30])^ PrP^C^ is responsible for AβO-mediated inhibition of long-term potentiation (LTP) in hippocampal slices and is also required for the manifestation of memory impairment in an AD mouse model. AβO-binding to PrP^C^ leads to activation of Fyn kinase. In addition, the AβO activation of Fyn leads to tau phosphorylation. Both metabotropic glutamate receptor 5 (mGluR5) and LPR1 have been identified as co-receptors required for the PrP^C^-bound AβO to activate Fyn.^[@r30])^ Fyn kinase phosphorylates N-methyl-D-aspartate receptor (NMDAR) and tau. Eventually NMDAR and tau (pTyr18) induce synaptic impairment and neurodegeneration (Fig. [6](#fig06){ref-type="fig"}).

Recently, Aβ~42~, which is associated with neurodegeneration in AD, has also been reported to act as a ligand of PrP^C^.^[@r138])^ However, the physiological role of PrP^C^ as an Aβ~42~-binding protein is not clear. Actually, Jung and our group have demonstrated that PrP^C^ is critical in Aβ~42~-mediated autophagy in neurons.^[@r138])^ The interaction of PrP^C^ with Beclin (BECN)1 facilitates the localization of BECN1 into lipid rafts and thus allows the activation of phosphatidylinositol 3-kinase (catalytic subunit type-3 or PI3KC3) complex in response to Aβ~42~, showing a beneficial role of PrP^C^ as a positive regulator of the BECN1-PI3KC3 complex in lipid rafts.

4. PrP^C^ and viral or bacterial infection
==========================================

Microglia is one of the major cell types that produce NO, which in fact plays a role in active cellular protection. Keshet *et al.* and our group have reported that NOS activity is significantly reduced in adult Zurich I *Prnp*^−/−^ mice (age \>100 days), whereas NOS activity in young Zrch I *Prnp*^−/−^ mice (≤30-day-old) is similar to that of wild-type *Prnp*^+/+^ mice.^[@r139],[@r140])^ To further elucidates the role of PrP^C^, we have infected wild type prion protein gene (*Prnp*^+/+^) and Zrch I or Rikn *Prnp*^−/−^ mice with encephalomyocarditis virus (EMCV)-B via an intracranial route.^[@r140])^ With regard to the inflammatory response in EMCV-B-infected mouse brains, mild to severe inflammatory changes have been observed only in 15-week-old but not in 6-week-old *Prnp*^+/+^ mice. There is histopathological evidence of suppressed microglial response in *Prnp*^−/−^ mice, whereas these are more enlarged apoptotic brain lesions after EMCV infection in *Prnp*^−/−^ mice.^[@r140])^

Decreases in the activities of certain enzymes (superoxide dismutase and catalase) have been observed in the brains of Zrch I *Prnp*^−/−^ mice.^[@r60],[@r66],[@r141])^ This enzyme-related deficiency may induce an intracellular oxidative state in mouse brain cells. Increased lipoperoxidation, a phenomenon reported in other neurodegenerative diseases such as Alzheimer's diseases and epilepsy,^[@r142],[@r143])^ has been observed in such mice. In the absence of PrP^C^, increased oxidation of lipids and protein has been observed in the brain.^[@r144])^ These findings suggest the physiological function of PrP^C^ is related to the cellular antioxidant defense system: viz., loss of the antioxidant defense system in *Prnp*^−/−^ mice may contribute to more severe lesions in the brain after EMCV infection.

A murine model of streptococcal sepsis that mimics many aspects of pathogenesis and immunity in the human disease has been investigated.^[@r145])^ Accordingly, they found that although Zrch I *Prnp*^−/−^ mice had impaired ability to clear Streptococcus pyogens at the inoculation site in the thigh muscle (an event that is largely neutrophil-dependent), these mice were protected from bacteremia and sepsis. This protection was accompanied by a standard decrease in most serum cytokine concentrations, the exceptions being IL-9 and interferon-α. It is tempting to speculate that the inability of Zrch I *Prnp*^−/−^ mice to mount a full-blown cytokine response may confer some protection from full-scale bacterial sepsis. Their findings are noteworthy in the context of the neutrophil response to zymosan-induced peritonitis in Zrch I *Prnp*^−/−^ mice,^[@r146])^ which may be caused by deficient IL-17 production leading to inadequate neutrophil migration.

Recently, it has been reported that mitochondria control the activation of NLRP3 (nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3) inflammasome, and that the inflammasome activation is negatively regulated by autophagy and positively regulated by reactive oxygen species (ROS).^[@r147])^ PrP^C^ has SOD activity and protects neurons from oxidative stress. Antioxidant PrP^C^ may contribute to suppressing inflammasome activation. The relationship between PrP^C^ and inflammasome remains to be fully elucidated.
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STI1
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![Number of BSE cases in the United Kingdom (U.K.) and Japan. An estimated 180,000 cattle were affected by BSE and killed in U.K. As a result, 156 people died in the 1990s as after having contracted the variant of CJD. To date, that number of human mortalities has risen to 177. In 1992, 37280 BSE cases were observed. Due to introduction of Feed ban for Specified Bovine Offal in 1988, number of BSE cases decreased from 1993 in U.K.^[@r148])^ In Japan, 36 cattle found to be affected by BSE, and were subsequently sacrificed between 2001--2009.](pjab-93-155-g001){#fig01}

![Neuroprotective function of cellular prion protein. Laminin receptor precursor (LRP) and Stress-inducible protein 1 (STI1) are the important signals protecting neurons from apoptosis. STI1 protective signals were mediated by cAMP/PKA pathway or MAPK/ERK pathway. Oncogene products Src also mediates protective signals through PI3K.](pjab-93-155-g002){#fig02}

![Phenotypes of *Prnp*^−/−^ mice established in several laboratories in the world. Different kinds of targeting cassette for *Prnp* are shown. The structures of constructs used to produce six lines of *Prnp*^−/−^ mice are explained. The structure of wild-type (WT) *Prnp* exon3 and PrP coding region (open box) is shown at the top. The selection markers are indicated by black boxes. The presence and absence of 3 splicing acceptors are correlated with ectopic expression of Doppel (Dpl) and development of late-onset ataxia induced by loss of Purkinje cells. Chronic demyelinating polyneuropathy (CDP) was observed in type-1 and type-2 *Prnp*^−/−^ mice. The selection markers were: PGK, mouse phosphoglycerate kinase promoter; NEO, neomycin phosphotransferase; HPRT, mouse hypoxanthine phosphoribosyltransferase; TK, human herpes simplex virus type 1 thymidine kinase promoter; MT, mouse metallothionein promoter; loxP, a 34 bp recombination site from phage P1. The restriction enzyme sites were: E, *EcoR*I; X, *Xba*I, S.A., splicing acceptor.^[@r149])^ Zurich type-2 knockout mouse produces while type-1 mouse does not produce doppel proteins. NT: not tested.](pjab-93-155-g003){#fig03}

![Capacity of truncated *Prnp*^−/−^ genes to rescue apoptosis when reintroduced to *Prnp*^−/−^ cells. Introducing empty vector (EM) to *Prnp*^−/−^ cells shows strong apoptosis. However, introducing Δ\#1 (octarepeat region (OR): aa 53-94 truncated) induces more potent apoptosis, showing the dominant negative effect of Δ\#1 gene. Similarly, introducing Δ\#2 (STI1 binding area; N-terminal half of hydrophobic region: aa 95-132 truncated) failed to rescue *Prnp*^−/−^ cells from apoptosis.](pjab-93-155-g004){#fig04}

![Summarized schematic representation of phenotypes of *Prnp*^−/−^ mice. Under the stressful conditions, *Prnp*^−/−^ mice showed various phenotypes. Detail of these phenotypes is summarized in reference [@r119]. *In vivo* studies have demonstrated that *Prnp*^−/−^ mice are more prone to seizure, depression, and induction of epilepsy as well as experience extensive cerebral damage following ischemic challenge or viral infection. In experimental autoimmune encephalomyelitis, *Prnp*^−/−^ mice reportedly have a more aggressive disease onset and clinical improvement during chronic phase than wild-type mice. *Prnp*^−/−^ mice demonstrated significantly greater increase in blood glucose concentration after intraperitoneal injection of glucose than wild-type mice. In mice given oral dextran sulfate, PrP^C^ indicated a potential protective role against inflammatory bowel disease.](pjab-93-155-g005){#fig05}

![PrP^C^-based lipid raft signaling platform. The co-receptors LRP1 and mGluR5 clusters with PrP^C^ upon AβO binding leads to activation of Fyn kinase. Fyn kinase phosphorylates NMDAR and tau. Subsequently tau becomes pTyr18 (phosphor-Tyr-18). NMDAR becomes pTyr1482NR2 (phosphor-Tyr-1482 NMDAR). NMDAR and tau (pTyr18) then induce synaptic impairment and neurodegeneration.](pjab-93-155-g006){#fig06}

###### 

Conventional virus-induced slow infections of man

  **Virus**                  Diseases
  -------------------------- ----------------------------------------------------------------------------------------------------------------------------------
  **RNA viruses**            
  ***Picornaviridae***        
  Poliovirus                 Chronic meningoencephalitis in immunodeficient patient
  Enterovirus                Virus-induced diabetes, subacute encephalitis
  Echovirus                  Chronic meningoencephalitis in immunodeficient patient
  ***Paramyxoviridae***       
  Measles                    Subacute sclerosing panencephalitis
  ***Togaviridae***           
  Rubella                    Progressive congenital rubella
  ***Flaviviridae***          
  Tick-borne encephalitis    Epilepsia partialis continua (Kozhevnikov's epilepsy), RSSE, progressive bulbar palsy in Russia
  Hepatitis C                Chronic hepatitis C (non-A, non-B hepatitis)
  ***Retroviridae***          
  Lentivirus HIV-1, HIV-2    HIV neuromyeloencephalopathy
  Oncovirus HTLV-1, HTLV-2   Adult T-cell leukemia and mycosis fungoides, HAM/TSP neuromyeloencephalopathy, Jamaican neuropathy, tropical spastic paraparesis
  ***Rhabdoviridae***         
  Rabies lyssavirus          Rabies encephalitis
                             
  **DNA viruses**            
  ***Adenoviridae***          
  Adenovirus 7 and 32        Subacute encephalitis
  ***Papovaridae***           
  JC virus                   Progressive multifocal leukoencephalopathy
  SV40                       Progressive multifocal leukoencephalopathy
  ***Hepadonoviridae***       
  Hepatitis B                Homologous serum jaundice
  ***Herpeviridae***          
  Herpes simplex             Subacute encephalitis
  Cytomegalovirus            Cytomegalovirus brain infection
  Epstein-Barr virus         Chronic infectious mononucleosis
  Varicella-Zoster virus     Herpes zoster (subacute encephalitis)
  Herpes saimiri (B-virus)   Chronic herpes B encephalitis

###### 

Transmissible spongiform encephalopathies with mutations responsible for inherited genetic forms of the disease

  --------------------------------------------------------------------------------------------------------------------------
  **In humans**
  Kuru
  Creutzfeldt-Jakob disease
   Sporadic
   Iatrogenic (human growth hormone, pituitary gonadotropin, dura matter and corneal transplants, stereotactic electrodes)
   Familial (178asn, 200lys, 210ile, octapeptides inserts 2, 4-9)
   Variant
  Gerstmann-Straussler-Scheinker syndrome (GSS is only genetic, mutations are classified according to disease phenotype)
  Fatal familial insomnia (178asn)
  **In Animals**
  Scrapie (sheep, goats, moufflon)
  Transmissible mink encephalopathy
  Chronic wasting disease (mule deer, elk)
  Bovine spongiform encephalopathy
  Exotic ungulate spongiform encephalopathy (nyala, gemsbok, Arabian oryx, greater kudu, eland)
  Feline spongiform encephalopathy (cats, albino tiger, puma, cheetah)
  --------------------------------------------------------------------------------------------------------------------------

[^1]: (Communicated by Masanori OTSUKA, M.J.A.)
